ClinicalTrials.gg
Sign In

Genital Diseases, Female clinical trials

The registry lists 161 studies for Genital Diseases, Female across more than 10 countries. 31 are recruiting or about to start. 101 of them are mainly about Genital Diseases, Female (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-06. Counting its 54 narrower conditions too, such as Ovarian Neoplasms: 12,083 studies, 2,850 open.

Get an email when these change. Save the Genital Diseases, Female studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
90
Status unknown
29
Recruiting
21
Not yet recruiting
8
Withdrawn
5
Active, not recruiting
4

Phase

Phase 2
17
Phase 3
8
Phase 4
7
Phase 1
4
Early Phase 1
1

Where

United States
31
Korea, Republic of
20
Turkey
15
Egypt
14
Italy
11
China
10

Who runs them

Kangbuk Samsung Hospital (5) · The Catholic University of Korea (4) · Derince Training and Research Hospital (3) · Zagazig University (3) · Intuitive Surgical (3) · Gedea Biotech AB (3) · Cairo University (3) · Seoul National University Hospital (3)

What is being tested here

Drugs under test in Genital Diseases, Female studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Remimazolam102
Tisotumab vedotin101
Cabergoline101
Lidocaine014
Dexmedetomidine003
Anlotinib002
Ketamine012
Paclitaxel012
Carboplatin012
Dovitinib002

Drug classes tested here Local anesthetics 7 · Tyrosine kinase inhibitors (TKIs) 4

Coming up

0phase 3 studies under way
8studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 8

Who these studies take

Of the 21 Genital Diseases, Female studies recruiting now, 10 (48%) set no upper age limit and 11 (52%) stop at 75 or younger. 3 (14%) take children under 18. 19 (90%) are for women only and 0 (0%) for men only; 4 (19%) take healthy volunteers.

Recruiting studies that take each age, of 21
AgeWomenMen
101 (5%)0 (0%)
1816 (76%)2 (10%)
3019 (90%)2 (10%)
4019 (90%)2 (10%)
5017 (81%)2 (10%)
6513 (62%)1 (5%)
7512 (57%)1 (5%)
8510 (48%)1 (5%)

Across all 161 studies, recruiting or not: 52% stop at 75 or younger and 40% at 65; 11% take children; 87% are for women only and 0% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Genital Diseases, Female studies take

Of 65 interventional studies with no phase under Genital Diseases, Female, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo8–28 · 65 studies—18 mo9–30 · 55 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 161. Browse all 161 → or search them.